| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/14/2006 | WO2006096515A2 Modified transferrin fusion proteins |
| 09/14/2006 | WO2006096473A2 Identification of polynucleotides for predicting activity of compunds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 09/14/2006 | WO2006096426A2 Targeted drug delivery of pain and addiction therapies using opioid receptor-mediated internalization |
| 09/14/2006 | WO2006096173A1 Pharmaceutical compositions and methods for peptide treatment |
| 09/14/2006 | WO2006096073A1 High pressure processing of metal ion lactoferrin |
| 09/14/2006 | WO2006095788A1 Particle and preparation containing the particle |
| 09/14/2006 | WO2006095711A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 09/14/2006 | WO2006095668A1 Microparticle and pharmaceutical composition |
| 09/14/2006 | WO2006095433A1 Therapeutic agent for bovine digestive system disease |
| 09/14/2006 | WO2006095347A2 VOLTAGE DEPENDENT ANION CHANNEL (VDACl) COMPOSITIONS AND METHODS OF USE THEREOF FOR REGULATING APOPTOSIS |
| 09/14/2006 | WO2006095267A1 Compositions for the treatment of tumour pathologies, comprising internalin b (in1b) of listeria monocytogene protein or a fragment thereof |
| 09/14/2006 | WO2006095167A1 Appetite-influencing medicaments |
| 09/14/2006 | WO2006095166A1 Modified pyy (3-36) peptides and their effects on feeding behaviour |
| 09/14/2006 | WO2006094973A1 Neuropeptides |
| 09/14/2006 | WO2006094971A1 Combination of interleukin-6 antagonists and antiproliferative drugs |
| 09/14/2006 | WO2006094813A2 Dimeric or multimeric microproteins |
| 09/14/2006 | WO2006094764A1 Formulation for aviptadil |
| 09/14/2006 | WO2006094724A2 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 09/14/2006 | WO2006094704A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/14/2006 | WO2006094664A1 Endoparasiticide |
| 09/14/2006 | WO2006094539A1 Methods and compositions for the treatment of cancer |
| 09/14/2006 | WO2006094536A1 Targeted plasminogen activator fusion proteins as thrombolytic agents |
| 09/14/2006 | WO2006094402A1 Novel hemoglobin scavenger receptor, cd163, and method of increasing cd163 expression on human stem cells and stimulation of erythroid progenitors |
| 09/14/2006 | WO2006094384A1 Use of interleukin 17e for the treatment of cancer |
| 09/14/2006 | WO2006094344A1 Methods and agents for regulating cellular interactions and development |
| 09/14/2006 | WO2006080017A3 Biologically active silver-coated proteins |
| 09/14/2006 | WO2006078870A3 Methods for treating adhesive capsulitis |
| 09/14/2006 | WO2006078268A3 A peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5 |
| 09/14/2006 | WO2006077427A3 Antiviral drug combinations |
| 09/14/2006 | WO2006069073A3 Use of angiopoietins in anti-tumor therapy |
| 09/14/2006 | WO2006065582A3 Muteins of fibroblast growth factor 21 |
| 09/14/2006 | WO2006056885A3 Igf-1 isoforms |
| 09/14/2006 | WO2006023210A3 Gp132: mehods and compositions for treating cancer |
| 09/14/2006 | WO2006020684A3 Methods of regulating differentiation and treating of multiple myeloma |
| 09/14/2006 | WO2006014579A3 Enhancing class i antigen presentation with synthetic sequences |
| 09/14/2006 | WO2006012492A3 Compositions and methods for viscosupplementation |
| 09/14/2006 | WO2006011792A3 Antimicrobial peptides derived from cap18 |
| 09/14/2006 | WO2006009438A3 Preparation for use of aspartate and vitamin b12 or biotin for regulating ketone bodies |
| 09/14/2006 | WO2006007417A3 Repair of tympanic membrane perforation |
| 09/14/2006 | WO2006005910A3 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose |
| 09/14/2006 | WO2005122712A3 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer’s amyloid-beta peptide |
| 09/14/2006 | WO2005117936A3 Method for enhancing or inhibiting insulin-like growth factor-i |
| 09/14/2006 | WO2005115136A3 Transgenic models of alzheimer’s disease and uses thereof in the treatment of a variety of neurodegenerative diseases |
| 09/14/2006 | WO2005115113A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/14/2006 | WO2005112976A3 Probiotic compounds from lactobacillus gg and uses therefor |
| 09/14/2006 | WO2005105093A3 METHOD OF ARRESTING THE SIDE EFFECTS OF µ-OPIOID RECEPTOR AGONISTS DURING THEIR ADMINISTRATION |
| 09/14/2006 | WO2005084710B1 Nanocell drug delivery system |
| 09/14/2006 | WO2005084301A3 Compositions and methods for treating diseases |
| 09/14/2006 | WO2005065418A3 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 09/14/2006 | WO2005007121A3 Mutant interleukin-2(il-2) polypeptides |
| 09/14/2006 | WO2005004928A3 Porous particulate collagen sponges |
| 09/14/2006 | WO2004108074A3 Vascular endothelial growth factor fusion constructs and uses thereof |
| 09/14/2006 | WO2004108066A3 Neuronal regeneration and compound administration methods |
| 09/14/2006 | WO2004098489A3 Compositions and methods for modulation of specific epitopes of hsp60 |
| 09/14/2006 | WO2004075836A3 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/14/2006 | WO2004062619A3 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 09/14/2006 | WO2004056849B1 Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria |
| 09/14/2006 | WO2004037192A3 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | WO2003072759A3 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 09/14/2006 | US20060206951 GABA B1A receptor disruptions, compositions and methods relating thereto |
| 09/14/2006 | US20060206949 Custom-made meganuclease and use thereof |
| 09/14/2006 | US20060206948 C-Reactive Protein (CRP); peptide biodrugs used to reduce body weight, adiposity, and alleviate insulin resistance and diabetes |
| 09/14/2006 | US20060205927 Templated native silk smectic gels |
| 09/14/2006 | US20060205926 Human growth hormone domains |
| 09/14/2006 | US20060205925 Inhibits hemolysis by interacting with the plasma proteins clusterin; histidine rich glycoprotein (HRG); Streptococcal Inhibitor of Complement-mediated lysis |
| 09/14/2006 | US20060205923 For detecting the presence of FIV antibodies in a biological sample, bycontacting a biological sample from an animal with the FIV polypeptide |
| 09/14/2006 | US20060205809 Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 09/14/2006 | US20060205771 Caspase inhibitors as anticancer agents |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060205688 Method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/14/2006 | US20060205675 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
| 09/14/2006 | US20060205674 Prodrugs containing novel bio-cleavable linkers |
| 09/14/2006 | US20060205673 2-Amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives |
| 09/14/2006 | US20060205672 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 09/14/2006 | US20060205671 Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury |
| 09/14/2006 | US20060205670 Anti-angiogenic compounds |
| 09/14/2006 | US20060205669 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 09/14/2006 | US20060205668 For therapy of spinal cord injury or stroke, by overcoming the inhibitory effects of myelin on axonal regeneration |
| 09/14/2006 | US20060205667 Wt1 substitution pepides |
| 09/14/2006 | US20060205666 Gamma-secretase inhibitors |
| 09/14/2006 | US20060205665 Non-basic amino acid sequence transporter peptide conjugated to biological effector; translocation across the membrane of eukaryotic cells |
| 09/14/2006 | US20060205664 N-terminal- and/or C-terminal-chemically modified polypeptides, used for the treamnet of respitory system disorders such as asthma, chronic obstructive pulmonary disease, bronchitis, cystic fibrosis, atopy, allergies, pneumonia, rhinitis or influenza |
| 09/14/2006 | US20060205663 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 09/14/2006 | US20060205662 Combination treatment with t-PA variant and low molecular weight heparin |
| 09/14/2006 | US20060205661 Novel albumin-free factor VIII formulations |
| 09/14/2006 | US20060205660 OB protein-immunoglobulin chimeras |
| 09/14/2006 | US20060205659 Peptide radical having 5-25 amino acids with its N-terminus capped with a monoester of fumaric acid; used to treat autoimmune diseases, mitochondrial diseases, and NF-kappaB mediated diseases and in transplantation medicine |
| 09/14/2006 | US20060205658 Irrigation solution and method for inhibition of pain and inflammation |
| 09/14/2006 | US20060205657 Irrigation solution and method for inhibition of pain and inflammation |
| 09/14/2006 | US20060205656 P-superfamily conopeptides |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205654 Screening methods for identifying disorders related to huXAG-1, huXAG-2 or huXAG-3 (colon cancer specific gene) activity |
| 09/14/2006 | US20060205652 Formulations and methods for delivery of growth factor analogs |
| 09/14/2006 | US20060205651 Method of treating cancer |
| 09/14/2006 | US20060205650 Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors |
| 09/14/2006 | US20060205649 Via operably linked to Neuron Restrictive Silencing Element (NRSE) that is recognized by Neuron-Restrictive Silencing Factor (NRSF) transcriptional repressor, reducing nicotinamide adenine dinucleotide (NADH) concentrations in cell by inhibiting glycolytic enzymes such as hexokinase |
| 09/14/2006 | US20060205648 Liquid, aqueous pharmaceutical compositions of factor VII polypeptides |
| 09/14/2006 | US20060205647 Somatostatin and somatostatin agonists for decreasing body weight |